Čes-slov Pediat 2025, 80(1):30-35 | DOI: 10.55095/CSPediatrie2024/060
Parvovirus B19 from the point of view of pediatric hematologist
- 1 Klinika dětské hematologie a onkologie, 2. lékařská fakulta, Univerzita Karlova a Fakultní nemocnice v Motole, Praha
- 2 Ústav lékařské mikrobiologie, 2. lékařská fakulta, Univerzita Karlova a Fakultní nemocnice v Motole, Praha
Parvovirus
B19 is the causative agent of classical childhood illness known as the 5th disease or erythema infectiosum. The occurrence has a seasonal character, with more dominant waves every 3 to 5 years. Remarkably higher incidence since 2023 is observed globally. Similarly to recent distinct waves od RSV and influenza, even in this case we can suspect a connection with covid pandemic (rapid contagion
after 2 years of social restrictions). The article describes a cohort of patients with PCR confirmed symptomatic parvovirus B19 infection during a period of 12 years (02/2012-06/2024) at the Department of Pediatric Hematology and Oncology, Motol University Hospital. We do not aim at thorough epidemiological analysis, but rather focus on bringing the topic to the czech pediatric community and
describe hematological variety of parvovirus B19 infection.
Keywords: parvovirus B19, erythema infectiosum, 5th disease, hematology, children, aplastic crisis
Received: September 9, 2024; Revised: October 16, 2024; Accepted: October 21, 2024; Published: February 1, 2025 Show citation
References
- Cossart Y, Parvovirus B19 finds a disease. Lancet 1981; 318: 988-989.
Go to original source...
Go to PubMed...
- Enders M, et al. Current epidemiological aspects of human parvovirus B19 infection during pregnancy and childhood in the western part of Germany. Epidemiol Infect 2007; 135(4): 563-569.
Go to original source...
Go to PubMed...
- Hübschen JM, et al. Phylogenetic analysis of human parvovirus b19 sequences from eleven different countries confirms the predominance of genotype 1 and suggests the spread of genotype 3b. J Clin Microbiol 2009; 47(11): 3735-8.
Go to original source...
Go to PubMed...
- Mossong J, et al. Parvovirus B19 infection in five European countries: Seroepidemiology, force of infection and maternal risk of infection. Epidemiol Infect 2008; 136: 1059-1068.
Go to original source...
Go to PubMed...
- Guillet M, et al. New atypical epidemiological profile of parvovirus B19 revealed by molecular screening of blood donations, France, winter 2023/24. Euro Surveill 2024; 29(21).
Go to original source...
- https://www.ecdc.europa.eu/en/publications-data/risks-posed-reported-increased-circulation-human-parvovirus-b19-eueea
- d'Humières C, et al. An unusual out break of parvovirus B19 infections, France, 2023 to 2024. Euro Surveill 2024; 29(25).
Go to original source...
Go to PubMed...
- Patalon T, et al. An outbreak of parvovirus B19 in Israel. Viruses 2023; 15: 2261.
Go to original source...
Go to PubMed...
- Vuković V, et al. Seroepidemiology of human parvovirus B19 infection among the population of Vojvodina, Serbia, over a 16-year period (2008-2023). Viruses 2024; 16: 180.
Go to original source...
Go to PubMed...
- Nordholm AC, et al. Epidemic of parvovirus B19 and disease severity in pregnant people, Denmark, January to March 2024. Euro Surveill 2024.
Go to original source...
- https://www.ecdc.europa.eu/en/publications-data/intensified-circulation-respiratory-syncytial-virus-rsv-and-associated-hospital
- https://szu.cz/aktuality/chripka-je-v-cr-dominantni-dosahla-urovne-epidemie/
- Weigel-Kelley KA, Yoder MC, Srivastava A. Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry. Blood 2003; 102(12): 3927-33.
Go to original source...
Go to PubMed...
- Xu M, Leskinen K, Gritti T, et al. Prevalence, cell tropism, and clinical impact of human parvovirus persistence in adenomatous, cancerous, inflamed, and healthy intestinal mucosa. Front Microbiol 2022; 13: 914181.
Go to original source...
Go to PubMed...
- Gigi, et al. Parvovirus B19 infection in pregnancy - a review. Eur J Obstet Gynecol Reprod Biol 2021; 264: 358-362.
Go to original source...
Go to PubMed...
- Bentata Y. Parvovirus B19 in kidney transplantation: keypoints and essen tail pitfalls to know. Infect Dis 2021; 53(6): 404-408.
Go to original source...
Go to PubMed...
- Algwaiz G, Alharbi A, Alsehaim K, et al. Hematologic manifestations of parvovirus B19 infection. Hematol Oncol Stem Cell Ther 2023; 16(4): 316-322.
Go to original source...
Go to PubMed...
- Vanspranghels, et al. Does an intrauterine exchange transfusion improve the fetal prognosis in parvovirus infection cases? Transfusion 2019; 59(1): 185-190.
Go to original source...
Go to PubMed...
- Hu X, Jia C, Wu J, et al. Towards the antiviral agents and nanotechnology-enabled approaches against parvovirus B19. Front Cell Infect Microbiol 2022; 12: 916012.
Go to original source...
Go to PubMed...
- Karna B, Jha SK, Al Zaabi E. Hemoglobin C disease. In: StatPearls [Internet]. Treasure Island (FL): StatPearlsPublishing 2024.
- Slavov S, et al. Human parvovirus B19: general considerations and impact on patients with sickle-cell disease and thalassemia and on blood transfusions. FEMS Immunol Med Microbiol 2011; 62: 247-262.
Go to original source...
Go to PubMed...
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.